mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-06 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-06 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-06 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |